TY - JOUR
T1 - The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice
AU - Zhang, Jinping
AU - Lee, Sang Myeong
AU - Shannon, Stephen
AU - Gao, Beixue
AU - Chen, Weimin
AU - Chen, An
AU - Divekar, Rohit
AU - McBurney, Michael W.
AU - Braley-Mullen, Helen
AU - Zaghouani, Habib
AU - Fang, Deyu
PY - 2009/10/1
Y1 - 2009/10/1
N2 - Although many self-reactive T cells are eliminated by negative selection in the thymus, some of these cells escape into the periphery, where they must be controlled by additional mechanisms. However, the molecular mechanisms underlying peripheral T cell tolerance and its maintenance remain largely undefined. In this study, we report that sirtuin 1 (Sirt1), a type III histone deacetylase, negatively regulates T cell activation and plays a major role in clonal T cell anergy in mice. In vivo, we found that loss of Sirt1 function resulted in abnormally increased T cell activation and a breakdown of CD4 + T cell tolerance. Conversely, upregulation of Sirt1 expression led to T cell anergy, in which the activity of the transcription factor AP-1 was substantially diminished. Furthermore, Sirt1 interacted with and deacetylated c-Jun, yielding an inactive AP-1 factor. In addition, Sirt1-deficient mice were unable to maintain T cell tolerance and developed severe experimental allergic encephalomyelitis as well as spontaneous autoimmunity. These findings provide insight into the molecular mechanisms of T cell activation and anergy, and we suggest that activators of Sirt1 may be useful as therapeutic agents for the treatment and/or prevention of autoimmune diseases.
AB - Although many self-reactive T cells are eliminated by negative selection in the thymus, some of these cells escape into the periphery, where they must be controlled by additional mechanisms. However, the molecular mechanisms underlying peripheral T cell tolerance and its maintenance remain largely undefined. In this study, we report that sirtuin 1 (Sirt1), a type III histone deacetylase, negatively regulates T cell activation and plays a major role in clonal T cell anergy in mice. In vivo, we found that loss of Sirt1 function resulted in abnormally increased T cell activation and a breakdown of CD4 + T cell tolerance. Conversely, upregulation of Sirt1 expression led to T cell anergy, in which the activity of the transcription factor AP-1 was substantially diminished. Furthermore, Sirt1 interacted with and deacetylated c-Jun, yielding an inactive AP-1 factor. In addition, Sirt1-deficient mice were unable to maintain T cell tolerance and developed severe experimental allergic encephalomyelitis as well as spontaneous autoimmunity. These findings provide insight into the molecular mechanisms of T cell activation and anergy, and we suggest that activators of Sirt1 may be useful as therapeutic agents for the treatment and/or prevention of autoimmune diseases.
UR - http://www.scopus.com/inward/record.url?scp=70349440053&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70349440053&partnerID=8YFLogxK
U2 - 10.1172/JCI38902
DO - 10.1172/JCI38902
M3 - Article
C2 - 19729833
AN - SCOPUS:70349440053
SN - 0021-9738
VL - 119
SP - 3048
EP - 3058
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 10
ER -